|
GTF2B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.047020E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.68100000000382E-05 |
| Normal-vs-Stage2 |
2.974400E-02 |
| Normal-vs-Stage3 |
1.144110E-02 |
| Normal-vs-Stage4 |
2.251000E-01 |
| Stage1-vs-Stage2 |
5.031800E-01 |
| Stage1-vs-Stage3 |
9.629800E-01 |
| Stage1-vs-Stage4 |
3.088000E-01 |
| Stage2-vs-Stage3 |
5.853400E-01 |
| Stage2-vs-Stage4 |
6.234600E-01 |
| Stage3-vs-Stage4 |
4.018000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.58739999999558E-05 |
| Normal-vs-AfricanAmerican |
1.286090E-02 |
| Normal-vs-Asian |
5.348200E-01 |
| Caucasian-vs-AfricanAmerican |
2.333600E-01 |
| Caucasian-vs-Asian |
3.073200E-01 |
| AfricanAmerican-vs-Asian |
5.881600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.003910E-04 |
| Normal-vs-Female |
6.925600E-02 |
| Male-vs-Female |
1.619820E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.012400E-02 |
| Normal-vs-Extreme_Weight |
6.035000E-04 |
| Normal-vs-Obese |
1.620670E-03 |
| Normal-vs-Extreme_Obese |
2.254400E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.313400E-01 |
| Normal_Weight-vs-Obese |
4.837200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.387600E-01 |
| Extreme_Weight-vs-Obese |
7.823400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.946800E-01 |
| Obese-vs-Extreme_Obese |
8.950400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.508380E-01 |
| Normal-vs-Age(41-60Yrs) |
4.756200E-03 |
| Normal-vs-Age(61-80Yrs) |
5.95589999999868E-05 |
| Normal-vs-Age(81-100Yrs) |
5.418100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.827600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.223800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.613600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.224200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.715200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.785800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.365700E-04 |
| Normal-VS-Type2 PRCC |
7.823800E-04 |
| Normal-VS-KIRP CIMP |
6.424400E-02 |
| Normal-VS-Unclassified PRCC |
1.411640E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.155200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.046200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.972400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.436000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.463600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.076400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.86559999999703E-05 |
| Normal-vs-N1 |
3.046200E-01 |
| Normal-vs-N2 |
4.975800E-02 |
| N0-vs-N1 |
6.815800E-02 |
| N0-vs-N2 |
8.765600E-01 |
| N1-vs-N2 |
3.754600E-01 |
|
|
